Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001306923-20-000008
Filing Date
2020-02-14
Accepted
2020-02-14 14:13:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 Clovis_13G_A6.txt SC 13G/A 10122
2 Clovis_13G_A6.pdf SC 13G/A 62492
  Complete submission text file 0001306923-20-000008.txt   97920
Mailing Address 470 UNIVERSITY AVE PALO ALTO CA 94301
Business Address 470 UNIVERSITY AVE PALO ALTO CA 94301 650-325-0772
Palo Alto Investors LP (Filed by) CIK: 0001306923 (see all company filings)

EIN.: 770558164 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Subject) CIK: 0001466301 (see all company filings)

EIN.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86488 | Film No.: 20617882
SIC: 2834 Pharmaceutical Preparations